Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 1
2018 1
2019 1
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J; PARADIGMS Study Group. Chitnis T, et al. N Engl J Med. 2018 Sep 13;379(11):1017-1027. doi: 10.1056/NEJMoa1800149. N Engl J Med. 2018. PMID: 30207920 Free article. Clinical Trial.
Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial.
Chitnis T, Banwell B, Kappos L, Arnold DL, Gücüyener K, Deiva K, Skripchenko N, Cui LY, Saubadu S, Hu W, Benamor M, Le-Halpere A, Truffinet P, Tardieu M; TERIKIDS Investigators. Chitnis T, et al. Lancet Neurol. 2021 Dec;20(12):1001-1011. doi: 10.1016/S1474-4422(21)00364-1. Lancet Neurol. 2021. PMID: 34800398 Clinical Trial.
[Symptomatic epilepsy in inflammatory demyelinating diseases].
Totolian NA, Borisova EV, Totolian AA, Miliukhina IV, Lapin SV, Kodzaeva AIu, Prakhova LN, Evdoshenko EP, Kairbekova EI, Skoromets AA. Totolian NA, et al. Among authors: kairbekova ei. Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2 Pt 2):38-51. Zh Nevrol Psikhiatr Im S S Korsakova. 2011. PMID: 21916156 Russian.
[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis].
Evdoshenko EP, Neofidov NA, Bakhtiyarova KZ, Davydovskaya MV, Kairbekova EI, Kolontareva YM, Malkova NA, Odinak MM, Popova EV, Sazonov DV, Stolyarov ID, Smagina IV, Fedyanin AS, Habirov FA, Khaibullin TI, Khachanova NV, Shchukin IA, Boyko AN. Evdoshenko EP, et al. Among authors: kairbekova ei. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(10. Vyp. 2):110-119. doi: 10.17116/jnevro2019119102110. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31934996 Clinical Trial. Russian.
[Experience of using genfaxon for treating patients with relapsing-remitting multiple sclerosis in the Russian Federation].
Bakhtiiarova KZ, Bragina OV, Vlasov IaV, Greshnova IV, Evdoshenko EP, Ivanishenkova EI, Kairbekova EI, Karnaukhova EN, Korotkevich NA, Leliukhina AV, Protasov IS, Rybina EV, Sazhnev AI, Skoromets AA, Soldatova OA, Trinitatskiĭ IuV, Fedianin AS, Chelnokova SN, Shabanova VD, Sharipova RR, Shchegol'kova EA, Iampol'skaia-Gosteva IA. Bakhtiiarova KZ, et al. Among authors: kairbekova ei. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(8):39-45. Zh Nevrol Psikhiatr Im S S Korsakova. 2014. PMID: 25345629 Clinical Trial. Russian.
[The use of ipidacrinum in chronic brain ischemia].
Skoromets AA, Mel'nikova EV, Kairbekova EI, Bondareva EA, Stukova LN, Kulagin PA. Skoromets AA, et al. Among authors: kairbekova ei. Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(1):50-2. Zh Nevrol Psikhiatr Im S S Korsakova. 2013. PMID: 23528495 Russian. No abstract available.